Submitted by kBLASTER Team on
Posted on January 7, 2015 by Josh Sandberg for OrthoSpine News
ALPHARETTA, GA. — Cartiva, Inc., (the “Company”) a developer of innovative solutions for the treatment of cartilage damage, osteoarthritis and other musculoskeletal conditions, announced today that it has received 510(k) clearance for its ProxiFuseTM Hammertoe Correction System (“ProxiFuse”). The ProxiFuse system, specifically developed for hammertoe fusion, is used for the fixation of osteotomies and reconstruction of the lesser toes following correction procedures for hammertoe, claw toe and mallet toe.
Go to kBLASTER to FDA 510(k) search for a primary predicate, multiple predicates or reference devices, and harness kBLASTER's uniquely effective result management features, so you can quickly build a successful 510(k) clearance strategy.